Hyaluronic Acid Increases Anti-Inflammatory Efficacy of Rectal 5-Amino Salicylic Acid Administration in a Murine Colitis Model
Open Access
- 1 September 2021
- journal article
- research article
- Published by The Korean Society of Applied Pharmacology in Biomolecules & Therapeutics
- Vol. 29 (5), 536-544
- https://doi.org/10.4062/biomolther.2020.227
Abstract
5-amino salicylic acid (5-ASA) is a standard therapy for the treatment of mild to moderate forms of inflammatory bowel diseases (IBD) whereas more severe forms involve the use of steroids and immunosuppressive drugs. Hyaluronic acid (HA) is a naturally occurring non-sulfated glycosaminoglycan that has shown epithelium protective effects in experimental colitis recently. In this study, both 5-ASA (30 mg/kg) and HA (15 mg/kg or 30 mg/kg) were administered rectally and investigated for their potential complementary therapeutic effects in moderate or severe murine colitis models. Intrarectal treatment of moderate and severe colitis with 5-ASA alone or HA alone at a dose of 30 mg/kg led to a significant decrease in clinical activity and histology scores, myeloperoxidase activity (MPO), TNF-alpha, IL-6 and IL-113 in colitis mice compared to untreated animals. The combination of HA (30 mg/kg) and 5-ASA in severe colitis led to a significant improvement of colitis compared to 5-ASA alone. Combined rectal therapy with HA and 5-ASA could be a treatment alternative for severe cases of IBD as it was the only treatment tested that was not significantly different from the healthy control group. This study further underlines the benefit of searching for yet unexplored drug combinations that show therapeutic potential in IBD without the need of designing completely new drug entities.Keywords
Funding Information
- Deutscher Akademischer Austauschdienst (91525759)
This publication has 37 references indexed in Scilit:
- Prostaglandin E2 and SOCS1 have a role in intestinal immune toleranceNature Communications, 2011
- The Potency of Hyaluronan of Different Molecular Weights in the Stimulation of Blood PhagocytesMediators of Inflammation, 2010
- Regulation of Colonic Epithelial Repair in Mice by Toll-Like Receptors and Hyaluronic AcidGastroenterology, 2009
- Absorption, Uptake and Tissue Affinity of High-Molecular-Weight Hyaluronan after Oral Administration in Rats and DogsJournal of Agricultural and Food Chemistry, 2008
- Epithelial restitution and wound healing in inflammatory bowel diseaseWorld Journal of Gastroenterology, 2008
- NF‐kB and caspases are involved in the hyaluronan and chondroitin‐4‐sulphate‐exerted antioxidant effect in fibroblast cultures exposed to oxidative stressJournal of Applied Toxicology, 2007
- Increased expression of tumor necrosis factor-α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phaseThe Esophagus, 2002
- High molecular weight hyaluronic acid inhibits advanced glycation endproduct‐induced NF‐κB activation and cytokine expressionFEBS Letters, 1999
- Intestinal glycosaminoglycans in neonatal necrotizing enterocolitisBritish Journal of Surgery, 1996
- The Catabolic Fate of Hyaluronic AcidConnective Tissue Research, 1986